Literature DB >> 23596326

Identification of candidate genes encoding an LDL-C QTL in baboons.

Genesio M Karere1, Jeremy P Glenn, Shifra Birnbaum, Sassan Hafizi, David L Rainwater, Michael C Mahaney, John L VandeBerg, Laura A Cox.   

Abstract

Cardiovascular disease (CVD) is the leading cause of death in developed countries, and dyslipidemia is a major risk factor for CVD. We previously identified a cluster of quantitative trait loci (QTL) on baboon chromosome 11 for multiple, related quantitative traits for serum LDL-cholesterol (LDL-C). Here we report differentially regulated hepatic genes encoding an LDL-C QTL that influences LDL-C levels in baboons. We performed hepatic whole-genome expression profiling for LDL-C-discordant baboons fed a high-cholesterol, high-fat (HCHF) diet for seven weeks. We detected expression of 117 genes within the QTL 2-LOD support interval. Three genes were differentially expressed in low LDL-C responders and 8 in high LDL-C responders in response to a HCHF diet. Seven genes (ACVR1B, CALCOCO1, DGKA, ERBB3, KRT73, MYL6B, TENC1) showed discordant expression between low and high LDL-C responders. To prioritize candidate genes, we integrated miRNA and mRNA expression profiles using network tools and found that four candidates (ACVR1B, DGKA, ERBB3, TENC1) were miRNA targets and that the miRNAs were inversely expressed to the target genes. Candidate gene expression was validated using QRT-PCR and Western blotting. This study reveals candidate genes that influence variation in LDL-C in baboons and potential genetic mechanisms for further investigation.

Entities:  

Keywords:  cardiovascular disease; diet-responsive liver gene expression; dyslipidemia; low density lipoprotein-cholesterol

Mesh:

Substances:

Year:  2013        PMID: 23596326      PMCID: PMC3679381          DOI: 10.1194/jlr.M032649

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  48 in total

1.  C1-TEN is a negative regulator of the Akt/PKB signal transduction pathway and inhibits cell survival, proliferation, and migration.

Authors:  Sassan Hafizi; Filiz Ibraimi; Björn Dahlbäck
Journal:  FASEB J       Date:  2005-04-07       Impact factor: 5.191

Review 2.  Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects.

Authors:  Ian Toma; Timothy A McCaffrey
Journal:  Cell Tissue Res       Date:  2011-05-31       Impact factor: 5.249

3.  Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7).

Authors:  Anders Sundqvist; Maria T Bengoechea-Alonso; Xin Ye; Vasyl Lukiyanchuk; Jianping Jin; J Wade Harper; Johan Ericsson
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

4.  Relationship of lipoprotein cholesterol concentrations to experimental atherosclerosis in baboons.

Authors:  H C McGill; C A McMahan; A W Kruski; G E Mott
Journal:  Arteriosclerosis       Date:  1981 Jan-Feb

5.  Transcription-dependent degradation controls the stability of the SREBP family of transcription factors.

Authors:  Anders Sundqvist; Johan Ericsson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-13       Impact factor: 11.205

6.  MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.

Authors:  Angelika Bonauer; Guillaume Carmona; Masayoshi Iwasaki; Marina Mione; Masamichi Koyanagi; Ariane Fischer; Jana Burchfield; Henrik Fox; Carmen Doebele; Kisho Ohtani; Emmanouil Chavakis; Michael Potente; Marc Tjwa; Carmen Urbich; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Science       Date:  2009-05-21       Impact factor: 47.728

7.  Lipid transfer inhibitor protein defines the participation of high density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP).

Authors:  Viktor M Paromov; Richard E Morton
Journal:  J Biol Chem       Date:  2003-08-07       Impact factor: 5.157

Review 8.  Roles of microRNAs in atherosclerosis and restenosis.

Authors:  Li-Jing Chen; Seh Hong Lim; Yi-Ting Yeh; Sheng-Chieh Lien; Jeng-Jiann Chiu
Journal:  J Biomed Sci       Date:  2012-08-29       Impact factor: 8.410

9.  Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.

Authors:  Katey J Rayner; Christine C Esau; Farah N Hussain; Allison L McDaniel; Stephanie M Marshall; Janine M van Gils; Tathagat D Ray; Frederick J Sheedy; Leigh Goedeke; Xueqing Liu; Oleg G Khatsenko; Vivek Kaimal; Cynthia J Lees; Carlos Fernandez-Hernando; Edward A Fisher; Ryan E Temel; Kathryn J Moore
Journal:  Nature       Date:  2011-10-19       Impact factor: 49.962

10.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease.

Authors:  Cristen J Willer; Serena Sanna; Anne U Jackson; Angelo Scuteri; Lori L Bonnycastle; Robert Clarke; Simon C Heath; Nicholas J Timpson; Samer S Najjar; Heather M Stringham; James Strait; William L Duren; Andrea Maschio; Fabio Busonero; Antonella Mulas; Giuseppe Albai; Amy J Swift; Mario A Morken; Narisu Narisu; Derrick Bennett; Sarah Parish; Haiqing Shen; Pilar Galan; Pierre Meneton; Serge Hercberg; Diana Zelenika; Wei-Min Chen; Yun Li; Laura J Scott; Paul A Scheet; Jouko Sundvall; Richard M Watanabe; Ramaiah Nagaraja; Shah Ebrahim; Debbie A Lawlor; Yoav Ben-Shlomo; George Davey-Smith; Alan R Shuldiner; Rory Collins; Richard N Bergman; Manuela Uda; Jaakko Tuomilehto; Antonio Cao; Francis S Collins; Edward Lakatta; G Mark Lathrop; Michael Boehnke; David Schlessinger; Karen L Mohlke; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2008-01-13       Impact factor: 38.330

View more
  9 in total

Review 1.  Baboons as a model to study genetics and epigenetics of human disease.

Authors:  Laura A Cox; Anthony G Comuzzie; Lorena M Havill; Genesio M Karere; Kimberly D Spradling; Michael C Mahaney; Peter W Nathanielsz; Daniel P Nicolella; Robert E Shade; Saroja Voruganti; John L VandeBerg
Journal:  ILAR J       Date:  2013

2.  Diet-induced early-stage atherosclerosis in baboons: Lipoproteins, atherogenesis, and arterial compliance.

Authors:  Michael C Mahaney; Genesio M Karere; David L Rainwater; Venkata S Voruganti; Edward J Dick; Michael A Owston; Karen S Rice; Laura A Cox; Anthony G Comuzzie; John L VandeBerg
Journal:  J Med Primatol       Date:  2017-06-16       Impact factor: 0.667

Review 3.  Genomic Tools for the Use of Nonhuman Primates in Translational Research.

Authors:  John D Harding
Journal:  ILAR J       Date:  2017-07-01

4.  Association between ErbB3 genetic polymorphisms and coronary artery disease in the Han and Uyghur populations of China.

Authors:  Buamina Maitusong; Xiang Xie; Yi-Tong Ma; Zhen-Yan Fu; Yi-Ning Yang; Xiao-Mei Li; Fen Liu; Bang-Dang Chen; Min-Tao Gai
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 5.  Evaluating the beneficial effects of dietary restrictions: A framework for precision nutrigeroscience.

Authors:  Kenneth A Wilson; Manish Chamoli; Tyler A Hilsabeck; Manish Pandey; Sakshi Bansal; Geetanjali Chawla; Pankaj Kapahi
Journal:  Cell Metab       Date:  2021-09-22       Impact factor: 31.373

6.  Intraspecific and interspecific investigations of skeletal DNA methylation and femur morphology in primates.

Authors:  Genevieve Housman; Ellen E Quillen; Anne C Stone
Journal:  Am J Phys Anthropol       Date:  2020-03-14       Impact factor: 2.868

7.  The non-human primate kidney transcriptome in fetal development.

Authors:  Kimberly D Spradling-Reeves; Jeremy P Glenn; Kenneth J Lange; Natalia Kuhn; Jacqueline J Coalson; Mark J Nijland; Cun Li; Peter W Nathanielsz; Laura A Cox
Journal:  J Med Primatol       Date:  2018-03-30       Impact factor: 0.667

Review 8.  Nonhuman Primates and Translational Research-Cardiovascular Disease.

Authors:  Laura A Cox; Michael Olivier; Kimberly Spradling-Reeves; Genesio M Karere; Anthony G Comuzzie; John L VandeBerg
Journal:  ILAR J       Date:  2017-12-01

9.  Efficiency of whole-exome sequencing in old world and new world primates using human capture reagents.

Authors:  Jeannie Chan; Wen Yao; Timothy D Howard; Gregory A Hawkins; Michael Olivier; Matthew J Jorgensen; Ian H Cheeseman; Shelley A Cole; Laura A Cox
Journal:  J Med Primatol       Date:  2021-04-19       Impact factor: 0.821

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.